Mallinckrodt Announces Availability of Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector in the U.S.

– Acthar Gel is the first and only medication in its class of adrenocorticotropic hormone products available in a self-injection device to treat a range of chronic and acute inflammatory and autoimmune conditions1 – DUBLIN, Aug. 6, 2024 /PRNewswire/ — Mallinckrodt plc, a global specialty…